INGN Q1 2022 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$80M-7.5% YoY

Gross Profit

$35M43.5% margin

Operating Income

-$14M-16.9% margin

Net Income

-$14M-17.7% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$22M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$475M

Total Liabilities

$116M

Stockholders' Equity

$358M

Cash & Equivalents

$213M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$87M	-7.5%
Gross Profit	$35M	$40M	-12.2%
Operating Income	-$14M	-$2M	-537.2%
Net Income	-$14M	-$732,000	-1841.8%

Geographic Segments

UNITED STATES

$52M65%

Non Us

$28M35%